Pas de connexion internet — affichage de la version enregistrée de la page.

Neurocrine Biosci…

USUSD
← Vers le screener

Neurocrine Biosciences Inc (MI:1NBIX) — Biotechnology: Biological Products (No Diagnostic Substances). Nombre de places boursières sur lesquelles les actions de la société sont cotées : 3. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.

À propos de l'entreprise

Site web
neurocrine.com
Secteur
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Siège social
San Diego, United States
PDG
Kyle W. Gano
Employés
2 500
Fondée
1992
Actions en circulation
101.65 M au 2026-07-22
Flottant
100.37 M
Capitalisation boursière
14.42 Md USD
Initiés
1.06%
Investisseurs institutionnels
102.84%
Secteur d'activité (SIC)
Biological Products, (No Diagnostic Substances)
Forme juridique
XTIQ
ISIN
US64125C1099
LEI
549300FECER0XBN49756
FCF
870 M USD
Dette
0
Résultats et FCF — pour les 12 mois à 30.06.2026 (dernier rapport de l'entreprise).
Description

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Bourses et tickers

BourseTickerDevisePrixType
US USA StocksNBIX principaleUSD141.25 -1.55%actions ordinaires
LSE London Stock Exchange0K6R IOBUSD138.12 +0.00%actions ordinaires
MI Borsa Italiana (Milan)1NBIX secondaireEUR129.8 -0.15%actions ordinaires

Cours sur 3 mois

jour de hausse jour de baisseSurvolez / touchez un jour — cours d'ouverture, de clôture, plus haut et plus bas

Actualités de cette semaine

Pas encore d'actualités du site de l'entreprise.

publicité

Principaux actionnaires

DétenteurParticipationActionsDate du rapport
Blackrock Inc.13.49%13.71 M2026-06-30
JPMORGAN CHASE & CO6.29%6.4 M2026-06-30
Dodge & Cox Inc.5.49%5.58 M2026-06-30
Vanguard Portfolio Manag…4.89%4.97 M2026-06-30
Vanguard Capital Managem…4.47%4.55 M2026-06-30
State Street Corporation4.31%4.39 M2026-06-30
Dodge & Cox Funds-Dodge…3.9%3.96 M2026-06-30
AQR Capital Management,…3.76%3.82 M2026-06-30
iShares Trust-iShares Co…3.46%3.52 M2026-08-31
VANGUARD INDEX FUNDS-Van…3.14%3.19 M2026-06-30
Renaissance Technologies…2.3%2.34 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.27%2.3 M2026-06-30
Geode Capital Management…2.1%2.14 M2026-06-30
Two Sigma Investments, L…2.04%2.08 M2026-06-30
J.P. Morgan Mutual Fd. I…1.34%1.36 M2026-06-30
VANGUARD INDEX FUNDS-Van…1.31%1.33 M2026-06-30
VANGUARD INDEX FUNDS-Van…1.13%1.15 M2026-06-30
JPMorgan Trust II-JPMorg…1.1%1.12 M2026-06-30
iShares Trust-iShares Bi…0.73%739 6702026-08-31
SPDR S&P MIDCAP 400 ETF…0.72%735 3422026-08-31
GORMAN KEVIN CHARLES (Di…≈0.51%517 7972026-09-11
GANO KYLE W (Chief Execu…≈0.15%154 7282026-09-11
LYONS GARY A (Director)≈0.12%122 1412026-05-21
BENEVICH ERIC S. (Office…≈0.07%67 2972026-09-11
LIPPOLDT DARIN M (Office…≈0.06%56 7932026-09-11
RASTETTER WILLIAM H (Dir…≈0.04%43 6782026-05-21
ABERNETHY MATTHEW C (Chi…≈0.04%42 8082026-09-14
POPS RICHARD F (Director…≈0.04%37 7982026-05-21
ROBERTS EIRY WYN (Office…≈0.04%35 6402025-02-14
COOKE JULIE SMITH (Offic…≈0.02%24 0252026-09-11